In This Section

Tumor Immunology and Immunotherapy

October 16-19, 2020
Westin Boston Waterfront
Boston, Massachusetts

Abstract Submission DeadlineFriday, July 24, 2020, 11:59 p.m. ET
Advance Registration DeadlineWednesday, September 2, 2020, 11:59 p.m. ET

Timothy A. Chan, Memorial Sloan Kettering Cancer Center, New York, New York
Charles G. Drake
, Columbia University Medical Center, New York, New York
Marcela V. Maus
, Massachusetts General Hospital, Boston, Massachusetts
Arlene H. Sharpe, Harvard Medical School, Boston, Massachusetts

This AACR Special Conference on Tumor Immunology and Immunotherapy is designed to integrate multidisciplinary facets of basic cancer immunology and immunotherapy to broaden our understanding of ways to harness the immune system to treat cancer. The hallmark of this series is also to encourage the effective exchange of ideas between basic cancer immunologists, non-immunologists, and clinical oncologists in order to develop approaches that translate to outcomes. This year’s program will feature international leaders in the field, who will expand our knowledge of T-cell and non-T-cell therapies; novel combinations; innate and adaptive checkpoints; and defining novel immunotherapy targets. These world-renowned oncologists and researchers will offer their insights on vaccines, neoantigens, oncolytic viruses, synthetic biology and novel approaches to immune engineering, all in the pursuit of understanding tumor evolution and creating better treatments. Please join in the conversation and network with investigators, from basic to translational scientists, from academia to industry.

Sign Up for Additional Information View Exhibitor Prospectus Brochure

For information on tabletop exhibits, please contact [email protected]. Space is limited.


Major Supporter

Bristol-Myers Squibb

Professional Educational Grant

Pfizer

Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available